genevax il-12-4532
Vaccineexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00775424)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- genevax il-12-4532
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03663998 | Phase 1 | Aug 15, 2015 | Bill and Melinda Gates Foundation, Imperial College London, University of London |
| NCT01496989 | Phase 1 | Dec 1, 2011 | Ichor Medical Systems Incorporated, International AIDS Vaccine Initiative, Profectus BioSciences, Inc. |
| NCT00775424 | Phase 1 | Sep 1, 2008 | Drexel University, University of Pennsylvania |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Drexel University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Ichor Medical Systems Incorporated | For profit | 1 | 0 | 1 | 2011 |
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2015 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Profectus BioSciences, Inc. | For profit | 1 | 0 | 1 | 2011 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2008 |
8 organizations
Page 1 / 1